Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 10684

I was honored to be interviewed by Nick Gillespie (editor in chief of Reason.com and Reason TV) in a 40 minute podcast about transhumanism and my run for California Governor as a libertarian. Give it a listen—or read the text of the conversation in the link below: http://reason.com/blog/2017/09/07/transhumanism-libertarianism-zoltan

The “California Dream of Transhumanism” on why he’s pro-robot, running for governor of California, and still angry about getting busted at 18 for selling pot.

Read more

The researchers, from the Mayo Clinic in Rochester, Minnesota, are calling for senolytic drugs to make the leap from animal research to human clinical trials. They outlined potential clinical trial scenarios in a paper published in the Journal of the American Geriatrics Society on Monday.

“This is one of the most exciting fields in all of medicine or science at the moment,” said Dr. James Kirkland, director of the Kogod Center on Aging at the Mayo Clinic and lead author of the new paper.

Read more

Equifax Inc, a provider of consumer credit scores, said on Thursday a hack exposed the personal details of potentially 143 million U.S. consumers between mid-May and July.

Continue Reading Below

The company’s shares were down 5.4 percent in after-market trading.

The company said criminals had accessed details including names, social security numbers, and, in some cases, driver’s license numbers.

Read more

Senolytic compounds hold promise to reverse aging in humans. Researcher James Kirkland publishes a list of senolytics in a review published yesterday. Two of the senolytics are currently in clinical trials. [Cover photo: Can Senolytic Drugs Reverse Aging? Credit: Getty Images.]

Imagine if you were able to reverse aging and bring your body back to its original health and vigor.

Researchers have already discovered a group of drugs called senolytics which perform this miraculous transformation in mice and are testing them in humans as we speak.

Read more